Lv21
130 积分 2024-03-01 加入
The Procalcitonin And Survival Study (PASS) – A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitoninand pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients
5个月前
已完结
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
5个月前
已完结
Artificial Extracellular Matrix Composed of Heparin-Mimicking Polymers for Efficient Anticoagulation and Promotion of Endothelial Cell Proliferation
9个月前
已完结
皖公网安备34019202002308
